For centuries, people have experimented with microdoses of psilocybin and peyote to relieve physical ailments and enhance feelings of well-being. Today, microdosing also includes MDMA, the prescription drug Ritalin, cannabis, and ketamine, which are all potentially hallucinogenic in higher doses but do not deliver a psychedelic response in microdoses.